ZA811125B - Vaccinal complex containing a specific antigen and vaccine containing it - Google Patents
Vaccinal complex containing a specific antigen and vaccine containing itInfo
- Publication number
- ZA811125B ZA811125B ZA00811125A ZA811125A ZA811125B ZA 811125 B ZA811125 B ZA 811125B ZA 00811125 A ZA00811125 A ZA 00811125A ZA 811125 A ZA811125 A ZA 811125A ZA 811125 B ZA811125 B ZA 811125B
- Authority
- ZA
- South Africa
- Prior art keywords
- specific antigen
- vaccinal
- vaccine
- complex
- complex containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/807—Hapten conjugated with peptide or protein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8003707A FR2475900A1 (fr) | 1980-02-20 | 1980-02-20 | Complexe vaccinal contenant un antigene specifique et vaccin le contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA811125B true ZA811125B (en) | 1982-03-31 |
Family
ID=9238765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA00811125A ZA811125B (en) | 1980-02-20 | 1981-02-20 | Vaccinal complex containing a specific antigen and vaccine containing it |
Country Status (10)
Country | Link |
---|---|
US (1) | US4460575A (de) |
EP (1) | EP0035429B1 (de) |
JP (1) | JPS56131523A (de) |
AT (1) | ATE13741T1 (de) |
AU (1) | AU543201B2 (de) |
CA (1) | CA1181691A (de) |
DE (1) | DE3170913D1 (de) |
ES (1) | ES8203226A1 (de) |
FR (1) | FR2475900A1 (de) |
ZA (1) | ZA811125B (de) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4870053A (en) * | 1980-09-19 | 1989-09-26 | Roussel Uclaf | Novel compositions and processes |
US5688645A (en) * | 1983-01-10 | 1997-11-18 | Gen-Probe Incorporated | Method for detecting, identifying, and quantitating non-viral organisms |
US4650675A (en) * | 1983-08-18 | 1987-03-17 | The Children's Medical Center Corporation | Oligonucleotide conjugates |
GB8404280D0 (en) * | 1984-02-17 | 1984-03-21 | Stanford J L | Biological preparations |
US4692332A (en) * | 1985-01-18 | 1987-09-08 | Mcmichael John | Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms |
US5346999A (en) * | 1985-01-18 | 1994-09-13 | Applied Biosystems, Inc. | Method of nucleic acid extraction |
US4689222A (en) * | 1985-01-18 | 1987-08-25 | Mcmichael John | Methods and materials for alleviation of pain symptoms of malignant neoplasia |
US4873090A (en) * | 1985-03-27 | 1989-10-10 | Broncostat Pty. Limited | Non-adjuvenated vaccine |
WO1986006279A1 (en) * | 1985-04-30 | 1986-11-06 | Scripps Clinic And Research Foundation | Acute phase protein modulating endotoxic activity of lipopolysaccharides, compositions and methods |
US4701323A (en) * | 1985-10-23 | 1987-10-20 | Iowa State University Research Foundation, Inc. | Vaccines for counteracting inhibition of neutrophil degranulation |
US4681761A (en) * | 1985-10-24 | 1987-07-21 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine |
FR2619122B1 (fr) * | 1987-08-03 | 1990-03-09 | Pasteur Institut | Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede |
EP0472467A3 (en) * | 1990-08-20 | 1993-03-17 | Chiba Flour Milling Co. Ltd. | Lps-containing analgesics and veterinary analgesics |
US7279162B1 (en) * | 1990-10-22 | 2007-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection |
US5506129A (en) * | 1991-05-24 | 1996-04-09 | Evans Medical Limited | Virus production |
JPH09163896A (ja) * | 1995-12-13 | 1997-06-24 | Sumitomo Pharmaceut Co Ltd | 胸膜炎病態モデル動物 |
FR2745186B1 (fr) * | 1996-02-26 | 1998-12-31 | Torossian Fernand Narbey | Complexe immunomodulateur et ses utilisations pour le traitement et la prevention des recidives des affections par helicobacter |
DE19703437A1 (de) * | 1997-01-30 | 1998-08-06 | Luitpold Pharma Gmbh | Gemische äußerer Membranen und/oder Zellwände von Bakterien zur oralen Immunisierung gegen Schleimhautinfektionen |
GB2325233B (en) * | 1997-05-16 | 2001-07-18 | Norsk Hydro As | Substrates having bound polysaccharides and bacterial nucleic acids |
US6610293B1 (en) | 1997-06-16 | 2003-08-26 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine | Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
US7250494B2 (en) * | 1998-06-15 | 2007-07-31 | Biosynexus Incorporated | Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
CN1896231B (zh) | 1998-08-06 | 2012-09-05 | 山景药品公司 | 分离四聚体尿酸氧化酶的方法 |
WO2002045742A2 (en) * | 2000-09-12 | 2002-06-13 | U.S. Army Medical Research And Materiel Command | Lipoteichoic acid immunogenic compositions and methods of making and using thereof |
GB2370838A (en) * | 2001-01-06 | 2002-07-10 | Benedikt Timmerman | Immunogenic complex |
GB2370839A (en) * | 2001-01-06 | 2002-07-10 | Benedikt Timmerman | Immunogenic complex useful for disease control |
MXPA04003852A (es) * | 2001-10-26 | 2005-02-17 | Univ Tennessee Res Foundation | Composiciones de vacuna estreptococica multivalente, y metodos para sus uso. |
US8148123B2 (en) | 2005-04-11 | 2012-04-03 | Savient Pharmaceuticals, Inc. | Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
LT3321359T (lt) | 2005-04-11 | 2021-05-10 | Horizon Pharma Rheumatology Llc | Urato oksidazės variantinės formos ir jų panaudojimas |
US20080159976A1 (en) * | 2005-04-11 | 2008-07-03 | Jacob Hartman | Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
BRPI0612942A2 (pt) | 2005-04-11 | 2012-10-09 | Savient Pharmaceuticals Inc | forma variante de oxidase de urato e uso do mesmo |
JP2008545665A (ja) * | 2005-05-23 | 2008-12-18 | ユニベルシテ ドゥ ジュネーブ | 高体温による処置のための注入可能な超常磁性ナノ粒子および高体温インプラントを形成するための使用 |
EP2013225B1 (de) | 2006-04-12 | 2014-12-17 | Crealta Pharmaceuticals LLC | Proteinaufreiningung mit hilfe von kationischen tensiden |
HUP1200205A3 (en) | 2009-06-25 | 2012-09-28 | Savient Pharmaceuticals | Method and kits for perdicting infusion reaction risk and antibody-mediated low of response by monitoring serum uric acid during pegylated uricare therapy |
US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3725545A (en) * | 1971-02-03 | 1973-04-03 | R Maes | Enhancement of antibody production by nucleic acid-polycation complexes |
FR2253499B1 (de) * | 1973-12-10 | 1977-11-04 | Fabre Sa Pierre | |
US3952097A (en) * | 1974-09-27 | 1976-04-20 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid |
FR2305990A1 (fr) * | 1975-04-02 | 1976-10-29 | Fabre Sa Pierre | Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens |
FR2360314A2 (fr) * | 1976-08-06 | 1978-03-03 | Fabre Sa Pierre | Nouveaux vaccins perfectionnes a base de fractions ribosomales |
FR2374911A1 (fr) * | 1976-12-21 | 1978-07-21 | Fabre Sa Pierre | Adjuvants d'immunite non specifique |
FR2388563A1 (fr) * | 1977-04-29 | 1978-11-24 | Fabre Sa Pierre | Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires |
US4285930A (en) * | 1977-12-08 | 1981-08-25 | Likhite Vilas V | Antigens comprising immunostimulant adjuvants and their use in immunotherapy |
-
1980
- 1980-02-20 FR FR8003707A patent/FR2475900A1/fr active Granted
-
1981
- 1981-02-19 CA CA000371264A patent/CA1181691A/en not_active Expired
- 1981-02-19 DE DE8181400258T patent/DE3170913D1/de not_active Expired
- 1981-02-19 AT AT81400258T patent/ATE13741T1/de not_active IP Right Cessation
- 1981-02-19 EP EP81400258A patent/EP0035429B1/de not_active Expired
- 1981-02-20 ES ES500567A patent/ES8203226A1/es not_active Expired
- 1981-02-20 AU AU67501/81A patent/AU543201B2/en not_active Expired
- 1981-02-20 JP JP2418381A patent/JPS56131523A/ja active Pending
- 1981-02-20 US US06/236,534 patent/US4460575A/en not_active Expired - Lifetime
- 1981-02-20 ZA ZA00811125A patent/ZA811125B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU543201B2 (en) | 1985-04-04 |
US4460575A (en) | 1984-07-17 |
FR2475900A1 (fr) | 1981-08-21 |
ES500567A0 (es) | 1982-04-16 |
EP0035429B1 (de) | 1985-06-12 |
JPS56131523A (en) | 1981-10-15 |
ES8203226A1 (es) | 1982-04-16 |
CA1181691A (en) | 1985-01-29 |
AU6750181A (en) | 1981-08-27 |
DE3170913D1 (en) | 1985-07-18 |
ATE13741T1 (de) | 1985-06-15 |
FR2475900B1 (de) | 1983-06-10 |
EP0035429A1 (de) | 1981-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3170913D1 (en) | Vaccinal complex containing a specific antigen and vaccine containing it | |
JPS5791915A (en) | Novel lipid composition useful for dietetics, resuscitation and treatment | |
PH20502A (en) | Quarternary 6,11-dihydro-dibenzo-(b,e)-thiepine-11-n-alkyl-norscopine ethers | |
NL300400I1 (en) | Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens | |
IL65835A0 (en) | Protozoal antigen,its preparation and vaccine containing it | |
JPS57116100A (en) | Novel d-homosteroid | |
FR2471785B1 (de) | ||
ZA792523B (en) | Curable compositions and process | |
EP0018579A3 (en) | Babesiosis antigen, vaccine and diagnostic reagent comprising it | |
IL65496A (en) | Protozoal antigen,its preparation and vaccine containing it | |
IL59663A0 (en) | Vaccines obtained from bacterial mutant strains | |
ZA905927B (en) | Biological preparation and its use | |
EP0050154A4 (de) | Impfstoff aus modifiziertem lebenden hundeparvovirus. | |
ZA837965B (en) | Novel strains of azospirillum,methods of growing the strains,compositions containing them and use thereof as biofertilizer | |
DE3068224D1 (en) | Vaccines from taxonomically similar organisms | |
GR73033B (de) | ||
IL58677A0 (en) | Process for the preparation of 1 ,3 -dihydroxy- -steroids and intermediates useful in the process | |
ZA83640B (en) | Ozone inactivated organisms as vaccines | |
EP0309898A3 (de) | Methode zur Induktion einer zytotoxischen T-Zell-Antwort | |
DE69130953D1 (de) | Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie | |
PT72211A (en) | Improvements in or relating to character recognition apparatus | |
IT7830203A0 (it) | Procedimento per rinforzare prodotti di carbone dolce. | |
DE2965852D1 (en) | Device for driving or extracting intramedullary nails | |
ZA806606B (en) | Specific antigen vaccine for tge in swine | |
CS194094B1 (en) | Vaccine against the aujeszki disease inactivated lyophilizised |